Tirzepatide 50mg

High-Potency Dual GIP/GLP-1 Agonist for Extended Research

Tirzepatide 50mg is a premium high-potency dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed for advanced metabolic research programs. This substantial 50mg supply provides researchers with an optimal balance of quantity and value for comprehensive studies in glucose regulation, weight management, and metabolic health.

Why Researchers Choose Tirzepatide 50mg:

• High-Potency Supply: 50mg provides substantial material for extended research protocols without excess waste
• Dual Mechanism Innovation: First-in-class dual GIP/GLP-1 receptor agonist for studying synergistic metabolic effects
• Superior Efficacy: Enhanced potency compared to single-receptor agonists in preclinical models
• Cost-Effective Research: Optimal quantity-to-price ratio for comprehensive research programs
• Multiple Experimental Runs: Sufficient supply for dose-response studies and replicate experiments
• Weight Management Focus: Investigate mechanisms of appetite suppression and energy expenditure
• Glucose Homeostasis: Explore insulin secretion, glucagon suppression, and glycemic control pathways
• Research-Grade Purity: Pharmaceutical-quality peptide (≥98%) for reliable, reproducible outcomes

Ideal Research Applications:

Perfect for laboratories conducting advanced metabolic research, obesity mechanism studies, diabetes pathophysiology investigations, and incretin biology. Tirzepatide's unique dual-agonist profile makes it invaluable for researchers exploring:

• Dual incretin receptor activation and synergistic metabolic effects
• Body weight regulation and adipose tissue metabolism
• Glucose-dependent insulin secretion mechanisms
• Appetite regulation and satiety signaling pathways
• Cardiovascular benefits of metabolic interventions
• Beta-cell function and pancreatic health preservation
• Lipid metabolism and hepatic steatosis reduction
• Energy expenditure and thermogenesis mechanisms
• Long-term metabolic adaptation studies

Technical Specifications:

• Quantity: 50mg (high-potency research supply)
• Type: Dual GIP/GLP-1 receptor agonist
• Structure: 39 amino acid synthetic peptide
• Form: Lyophilized powder for reconstitution
• Purity: ≥98% (HPLC verified)
• Molecular Weight: ~4813 Da
• Storage: Store at 2-8°C before reconstitution; -20°C after reconstitution
• Solubility: Reconstitute with bacteriostatic water
• Stability: Enhanced stability profile with C20 fatty acid modification
• Shelf Life: Extended stability when stored properly

Research Advantages:

Tirzepatide represents a paradigm shift in incretin-based research, combining GIP and GLP-1 receptor activation to produce superior metabolic outcomes. The 50mg supply provides researchers with the perfect amount for comprehensive studies while maintaining cost-effectiveness.

Unique Mechanism: Unlike single-receptor agonists, Tirzepatide activates both GIP and GLP-1 receptors, leading to enhanced insulin secretion, reduced glucagon levels, delayed gastric emptying, and significant appetite suppression. The GIP component may also contribute to improved lipid metabolism and insulin sensitivity.

Research Breakthrough: Clinical studies have demonstrated unprecedented weight loss (up to 22.5% body weight reduction) and glycemic control with tirzepatide, making it a critical tool for understanding next-generation metabolic therapeutics and obesity treatment mechanisms.

Value Proposition: The 50mg format strikes the ideal balance between having sufficient material for comprehensive research programs and maintaining cost-effectiveness. This quantity is perfect for laboratories conducting multiple experiments without the commitment of larger bulk purchases.

Experimental Flexibility: With 50mg, researchers can conduct dose-ranging studies, compare efficacy across different experimental models, and maintain consistency across multiple research phases without frequent reordering.

Important Disclaimer: This product is sold exclusively for research and laboratory purposes. Not intended for human consumption, therapeutic use, weight loss applications, or veterinary use. For in vitro and animal research only.

*Price per vial.
*This product is in powder form and is not reconstituted.
*For research purposes only.
*Tested at 99% purity.
*Free shipping.
*All sales final.